TECX
NASDAQ · Biotechnology
Tectonic Therapeutic Inc
$29.88
-0.95 (-3.08%)
Open$30.75
Previous Close$30.83
Day High$31.42
Day Low$29.42
52W High$31.88
52W Low$13.70
Volume—
Avg Volume850.2K
Market Cap393.04M
P/E Ratio—
EPS$-3.85
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+24.6% upside
Current
$29.88
$29.88
Target
$37.23
$37.23
$31.47
$37.23 avg
$57.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 64.42M | 64.45M | 57.14M |
| Net Income | 9.98M | 8.55M | 7.27M |
| Profit Margin | 15.5% | 13.3% | 12.7% |
| EBITDA | 14.26M | 12.01M | 10.46M |
| Free Cash Flow | 6.92M | 8.94M | 6.74M |
| Rev Growth | +22.9% | -2.6% | -4.3% |
| Debt/Equity | 0.17 | 0.17 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |